Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M334Revenue (TTM) $M24.6Net Margin (%)-472.8Altman Z-Score-7.2
Enterprise Value $M365EPS (TTM) $-1.4Operating Margin %-430.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-494.7Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-23.9Quick Ratio3.1Cash flow > EarningsY
Price/Sales13.05-y EBITDA Growth Rate %4.9Current Ratio3.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-310.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M87.1ROIC % (ttm)-1,248.5Gross Margin Increase y-yN

Gurus Latest Trades with AGEN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

AGEN is held by these investors:

AGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
INCYTE CORP10% Owner 2017-02-14Buy10,000,000$6-36.17view
WIINBERG ULFDirector 2016-09-06Buy30,000$6.29-39.11view
ARMEN GARO HChairman & CEO 2016-05-09Buy100,000$3.1820.44view
ARMEN GARO HChairman & CEO 2016-05-09Buy100,000$3.1820.44view
Baysal OzerChief Business Officer 2016-05-05Buy2,250$3.123.55view
ARMEN GARO HChairman & CEO 2016-03-07Buy200,000$4.03-4.96view
ARMEN GARO HChairman & CEO 2015-12-29Sell219,576$4.59-16.56view
ARMEN GARO HChairman & CEO 2015-09-25Buy100,000$5.03-23.86view
Ballantyne Charles EvanCFO 2015-09-25Buy10,000$5.05-24.16view
Malik ShahzadDirector 2015-04-29Sell1,107,377$7.11-46.13view

Quarterly/Annual Reports about AGEN:

News about AGEN:

Articles On GuruFocus.com
Insiders Roundup: Facebook, Twitter, Kellogg Feb 17 2017 
Weekly CEO Buys Highlights Mar 14 2016 
Paul Tudor Jones' Highest Performing Stocks Jul 13 2015 
Agenus Inc.: Ingeniously Designed Vaccines To Galvanized Tomorrow's Medicine Jul 25 2014 
5 Speculative Biotech Stocks to Consider Buying Now Jan 24 2012 
Weekly CEO Buys Highlight: CTAS, VRX, TAT, AGEN, MRK Aug 20 2011 
Chairman & CEO of Agenus Inc. (AGEN) Garo Armen Buys 2,150,976 Shares Aug 18 2011 
Antigenics Inc. Reports Operating Results (10-K) Mar 16 2011 
Antigenics Inc. Reports Operating Results (10-Q) Nov 09 2010 
Antigenics Inc. (AGEN) CFO Shalini Sharp sells 1,500 Shares Oct 28 2010 

More From Other Websites
Trials Of Agenus Inc (AGEN) Cancer Vaccine Ends In Absolute Failure Feb 23 2017
[2/23] This Week’s Earnings Revisions Movers Feb 23 2017
Lexington's Agenus quietly discloses failure of cancer vaccine trial Feb 22 2017
AGENUS INC Files SEC form 8-K, Regulation FD Disclosure Feb 21 2017
​Lexington-based Agenus reworks Incyte pact, freeing up $80M in cash Feb 14 2017
Incyte and Agenus Amend Drug Licensing Deal Feb 14 2017
AGENUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Feb 14 2017
Incyte and Agenus Amend Collaboration Agreement Feb 14 2017
Agenus, Inc. – Value Analysis (NASDAQ:AGEN) : February 8, 2017 Feb 08 2017
Agenus, Inc. breached its 50 day moving average in a Bullish Manner : AGEN-US : February 7, 2017 Feb 07 2017
Agenus Appoints Jean-Marie Cuillerot, M.D. Chief Medical Officer Jan 30 2017
Agenus Inc (AGEN) Incorporates NCI In Evaluation Of Prophage-Keytruda Combo Jan 19 2017
Clinical Trial Hopes Drugs Help Body Fight Cancer Jan 18 2017
Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo Jan 18 2017
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)